Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 109
interventional 72
Observational 35
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 34
Device 12
Behavioral 10
Drug|placebo 5
Procedure 2
Radiation 2
Behavioral|Biological|Diagnostic Test|Other 1
Behavioral|Device|Other 1
Behavioral|Device|placebo 1
Biological|placebo 1
Device|Drug 1
Diagnostic Test 1
Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 40
Canada 8
France 4
Italy 3
Taiwan 3
Germany 2
NA 2
Israel|Sweden|United Kingdom 1
Korea, Republic of 1
Spain 1
Sweden 1
United Kingdom 1
United States|Australia|Canada|Croatia|Germany|Italy|Netherlands|Poland|Romania|Singapore|Spain|United Kingdom 1
United States|Canada 1
United States|Canada|Germany|Italy|Netherlands|United Kingdom 1
United States|Canada|United Kingdom 1
United States|Germany|Slovakia|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 56
2 6
3 2
5 2
8 1
9 2
11 2
67 1

Phase

Phase Study_Count
N/A 28
Phase 1 13
Phase 2 13
Phase 1/Phase 2 6
Early Phase 1 4
Phase 3 4
Phase 4 4

Number of Arms

Number_of_Arms Count_of_Studies
1 23
2 28
3 7
4 3
5 3
NA 8

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 20.0 6.0000 6.00000 12.00 7 5.0 22.00
1st Qu. 20.0 23.0000 12.00000 12.00 28 14.0 43.00
Median 25.0 58.5000 16.00000 18.50 34 108.5 65.50
Mean 26.5 150.0714 35.92308 21.00 54 110.5 663.25
3rd Qu. 31.5 81.2500 33.00000 28.75 52 205.0 685.75
Max. 36.0 1505.0000 168.00000 35.00 220 220.0 2500.00

Trial Group Type

group_type Group_Count
Experimental 83
Active Comparator 16
Other 8
Placebo Comparator 8
Sham Comparator 8
NA 8
No Intervention 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 30
Single Group Assignment 28
Crossover Assignment 12
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 42
Diagnostic 16
Supportive Care 5
Basic Science 3
Other 3
NA 2
Prevention 1

Observational Studies

Studies by Country

Country Study_Count
United States 23
United States|Canada 4
Canada 2
Denmark|France|Germany|Italy|Poland|Spain|Switzerland|United Kingdom 1
Germany|India|Sri Lanka 1
NA 1
Norway 1
Pakistan 1
United States|Germany|South Africa 1

Sites per Study

Site_count Study_Count
1 20
3 5
4 1
6 1
7 1
8 1
12 2
15 1
16 1
18 1
19 1

Enrollment Metrics

Measure Observational
Min 20.000
1st Qu 47.000
Median 200.000
Mean 1229.343
3rd Qu 800.000
Max 15000.000

Observation Model

observational_model Study_Count
Cohort 20
Case-Control 4
Case-Only 4
NA 3
Family-Based 2
Case Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 27
Cross-Sectional 5
Other 1
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Finland 1
United States|Australia 1

Sites per Study

Site_count Study_Count
2 1
3 1

Enrollment Metrics

Measure Registries
Min 126.0
1st Qu 5094.5
Median 10063.0
Mean 10063.0
3rd Qu 15031.5
Max 20000.0

Registry Model

observational_model Study_Count
Case-Control 1
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
100 Years 1
18 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04428112 Rural Dementia Caregiver Project https://ClinicalTrials.gov/show/NCT04428112 Recruiting University of California, San Francisco 2022-06-30
NCT03406429 rTMS as a Treatment for PPA https://ClinicalTrials.gov/show/NCT03406429 Active, not recruiting Massachusetts General Hospital 2021-01-01
NCT03283449 Tau PET Imaging in Atypical Dementias https://ClinicalTrials.gov/show/NCT03283449 Recruiting Northwestern University 2022-02-28
NCT03272230 Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System https://ClinicalTrials.gov/show/NCT03272230 Recruiting Institut National de la Santé Et de la Recherche Médicale, France 2019-07-31
NCT03260920 Intranasal Oxytocin for Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT03260920 Recruiting Lawson Health Research Institute 2023-09-01
NCT03174938 The Swedish BioFINDER 2 Study https://ClinicalTrials.gov/show/NCT03174938 Recruiting Skane University Hospital 2028-12-31
NCT03174886 A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT03174886 Active, not recruiting Axon Neuroscience SE 2020-11-30
NCT03076671 More Than a Movement Disorder: Applying Palliative Care to Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03076671 Recruiting University of Colorado, Denver 2021-03-31
NCT02999282 Rehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects https://ClinicalTrials.gov/show/NCT02999282 Completed Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2019-06-30
NCT02945774 Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias https://ClinicalTrials.gov/show/NCT02945774 Recruiting Lawson Health Research Institute 2020-02-29
NCT02939547 Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) https://ClinicalTrials.gov/show/NCT02939547 Completed CTD Holdings, Inc. 2019-10-22
NCT02928848 Baseline Severity and tDCS in PPA https://ClinicalTrials.gov/show/NCT02928848 Completed University of Pennsylvania 2020-04-30
NCT02912793 Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients https://ClinicalTrials.gov/show/NCT02912793 Recruiting CTD Holdings, Inc. 2020-10-31
NCT02862210 Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT02862210 Recruiting Columbia University 2020-09-30
NCT02736695 Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT02736695 Enrolling by invitation Mayo Clinic 2022-06-01
NCT02676843 Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations https://ClinicalTrials.gov/show/NCT02676843 Completed Columbia University 2018-11-25
NCT02675270 Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT02675270 Recruiting Georgetown University 2021-04-30
NCT02606422 tDCS Intervention in Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT02606422 Recruiting Johns Hopkins University 2021-04-30
NCT02439853 Communication Bridge Speech Therapy Research Study https://ClinicalTrials.gov/show/NCT02439853 Active, not recruiting Northwestern University 2019-12-31
NCT02541097 Preventing Language Decline in Dementia https://ClinicalTrials.gov/show/NCT02541097 Completed Baycrest 2018-12-31
NCT02506036 Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT02506036 Completed Johns Hopkins University 2017-05-31
NCT02496312 Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated. https://ClinicalTrials.gov/show/NCT02496312 Completed Institut National de la Santé Et de la Recherche Médicale, France 2015-10-02
NCT02236832 Study of the Neural Basis of Analogical Reasoning https://ClinicalTrials.gov/show/NCT02236832 Recruiting Institut National de la Santé Et de la Recherche Médicale, France 2020-02-29
NCT02124083 Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 https://ClinicalTrials.gov/show/NCT02124083 Completed National Institutes of Health Clinical Center (CC) 2016-12-13
NCT02103894 Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects https://ClinicalTrials.gov/show/NCT02103894 Completed Molecular NeuroImaging 2016-08-31
NCT01937013 Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT01937013 Completed Lawson Health Research Institute 2017-12-21
NCT01890343 Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer’s Disease and Normal Controls. https://ClinicalTrials.gov/show/NCT01890343 Completed Avid Radiopharmaceuticals 2012-12-31
NCT01818661 Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech https://ClinicalTrials.gov/show/NCT01818661 Recruiting Mayo Clinic 2023-06-01
NCT01760564 Application of Miglustat in Patients With Niemann-Pick Type C https://ClinicalTrials.gov/show/NCT01760564 Completed National Taiwan University Hospital 2010-12-31
NCT01747135 Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease https://ClinicalTrials.gov/show/NCT01747135 Completed Mallinckrodt 2017-03-31
NCT01723553 Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD https://ClinicalTrials.gov/show/NCT01723553 Completed Mayo Clinic 2015-03-31
NCT01386333 Safety Study of Intranasal Oxytocin in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT01386333 Completed Lawson Health Research Institute 2013-10-31
NCT04309253 The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy https://ClinicalTrials.gov/show/NCT04309253 Recruiting Chang Gung Memorial Hospital 2023-09-18
NCT04220021 Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD https://ClinicalTrials.gov/show/NCT04220021 Recruiting University of Florida 2021-05-31
NCT04157244 The Music, Sleep and Dementia Study https://ClinicalTrials.gov/show/NCT04157244 Active, not recruiting University of Pennsylvania 2021-06-10
NCT04115384 Intranasal Insulin in Frontotemporal Dementia (FTD) https://ClinicalTrials.gov/show/NCT04115384 Recruiting HealthPartners Institute 2020-09-30
NCT04045990 Network Modulation in Alzheimer’s Disease https://ClinicalTrials.gov/show/NCT04045990 Recruiting Brigham and Women’s Hospital 2020-12-31
NCT03987295 A Study to Evaluate Safety of Long-term AL001 Dosing in FTD Patients https://ClinicalTrials.gov/show/NCT03987295 Recruiting Alector Inc. 2021-03-30
NCT03893071 Open‐Label Study of Long‐Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann‐Pick Disease Type C https://ClinicalTrials.gov/show/NCT03893071 Recruiting CTD Holdings, Inc. 2021-03-31
NCT03887533 Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1 https://ClinicalTrials.gov/show/NCT03887533 Recruiting National Institutes of Health Clinical Center (CC) 2022-01-01
NCT03887481 Determining the Influence of Atrophy on Efficacy of tDCS in Treating Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT03887481 Recruiting Johns Hopkins University 2025-10-31
NCT03828383 In-Home Technology for Dementia Caregivers https://ClinicalTrials.gov/show/NCT03828383 Recruiting University of California, Berkeley 2021-02-28
NCT03759639 N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) https://ClinicalTrials.gov/show/NCT03759639 Active, not recruiting IntraBio Inc 2020-06-01
NCT03728582 Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy https://ClinicalTrials.gov/show/NCT03728582 Recruiting Johns Hopkins University 2023-04-30
NCT03682185 The Healthy Patterns Study https://ClinicalTrials.gov/show/NCT03682185 Recruiting University of Pennsylvania 2021-05-31
NCT03636204 A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin Mutation https://ClinicalTrials.gov/show/NCT03636204 Recruiting Alector Inc. 2019-12-31
NCT03580954 Transcranial Magnetic Stimulation in Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT03580954 Completed Hospital San Carlos, Madrid 2020-03-10
NCT03510572 Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain https://ClinicalTrials.gov/show/NCT03510572 Recruiting Asan Medical Center 2019-07-31
NCT03481933 Evaluation of a Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia https://ClinicalTrials.gov/show/NCT03481933 Recruiting Assistance Publique - Hôpitaux de Paris 2021-08-31
NCT03471143 Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C https://ClinicalTrials.gov/show/NCT03471143 Recruiting Washington University School of Medicine 2022-02-28
NCT03422250 Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer’s Disease and Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT03422250 Completed IRCCS Centro San Giovanni di Dio Fatebenefratelli 2018-11-03
NCT01056965 Davunetide (AL-108) in Predicted Tauopathies - Pilot Study https://ClinicalTrials.gov/show/NCT01056965 Completed University of California, San Francisco 2012-12-31
NCT01002300 Oxytocin and Social Cognition in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT01002300 Completed Lawson Health Research Institute 2010-11-30
NCT00975689 Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine https://ClinicalTrials.gov/show/NCT00975689 Completed National Institutes of Health Clinical Center (CC) 2010-11-30
NCT00957710 Language Treatment for Progressive Aphasia https://ClinicalTrials.gov/show/NCT00957710 Completed Baycrest 2010-07-31
NCT00950430 Imaging of Brain Amyloid Plaques in the Aging Population https://ClinicalTrials.gov/show/NCT00950430 Enrolling by invitation Mayo Clinic 2023-04-30
NCT03923517 RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia https://ClinicalTrials.gov/show/NCT03923517 Completed Technische Universität München 2019-05-30
NCT03625128 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer’s Disease, Other Dementias and Normal Controls https://ClinicalTrials.gov/show/NCT03625128 Completed Chang Gung Memorial Hospital 2018-08-03
NCT00811122 Biodistribution of 11C-PIB PET in Alzheimer’s Disease, Frontotemporal Dementia, and Cognitively Normal Elderly https://ClinicalTrials.gov/show/NCT00811122 Active, not recruiting University of Utah 2022-04-30
NCT01626378 Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) https://ClinicalTrials.gov/show/NCT01626378 Completed TauRx Therapeutics Ltd 2016-02-29
NCT03040713 Flortaucipir PET Imaging in Subjects With FTD https://ClinicalTrials.gov/show/NCT03040713 Completed Avid Radiopharmaceuticals 2018-10-24
NCT03371706 Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT03371706 Recruiting Northwestern University 2023-02-01
NCT01623284 PiB PET Scanning in Speech and Language Based Dementias https://ClinicalTrials.gov/show/NCT01623284 Completed Mayo Clinic 2015-01-31
NCT04187391 The Effects of a Multimodal Approach for the Treatment of Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT04187391 Recruiting IRCCS Centro San Giovanni di Dio Fatebenefratelli 2022-12-15
NCT00730314 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells https://ClinicalTrials.gov/show/NCT00730314 Completed Children’s Hospital Los Angeles 2015-08-31
NCT00604591 Effects of Tolcapone on Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00604591 Completed Columbia University 2014-10-31
NCT00594737 Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00594737 Completed Rotman Research Institute at Baycrest 2012-06-30
NCT00545974 Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00545974 Completed University of California, San Francisco 2012-12-31
NCT00416169 A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00416169 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00376051 Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00376051 Completed Sunnybrook Health Sciences Centre 2009-07-31
NCT00200538 Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients https://ClinicalTrials.gov/show/NCT00200538 Completed Nantes University Hospital NA
NCT00077896 Direct Current Brain Polarization in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00077896 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03313011 The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech https://ClinicalTrials.gov/show/NCT03313011 Recruiting Mayo Clinic 2021-07-31
NCT03225144 Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT03225144 Recruiting National Institutes of Health Clinical Center (CC) 2025-10-30
NCT03153371 Early-onset Alzheimer’s Disease Phenotypes: Neuropsychology and Neural Networks https://ClinicalTrials.gov/show/NCT03153371 Recruiting University of California, Los Angeles 2021-03-31
NCT03088956 Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD) https://ClinicalTrials.gov/show/NCT03088956 Completed Biogen 2019-09-23
NCT02966145 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 https://ClinicalTrials.gov/show/NCT02966145 Recruiting University of California, San Francisco 2021-12-31
NCT02964637 Diagnosing Frontotemporal Lobar Degeneration https://ClinicalTrials.gov/show/NCT02964637 Recruiting University Health Network, Toronto 2019-12-31
NCT02435030 A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C https://ClinicalTrials.gov/show/NCT02435030 Completed Orphazyme 2017-05-31
NCT02372773 Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects https://ClinicalTrials.gov/show/NCT02372773 Recruiting Mayo Clinic 2020-06-30
NCT02365922 Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) https://ClinicalTrials.gov/show/NCT02365922 Recruiting University of California, San Francisco 2020-09-30
NCT02327845 Phenotype, Genotype & Biomarkers in ALS and Related Disorders https://ClinicalTrials.gov/show/NCT02327845 Recruiting University of Miami 2021-06-30
NCT01306604 Biomarker for Niemann Pick Type C Disease (BioNPC) https://ClinicalTrials.gov/show/NCT01306604 Active, not recruiting Centogene AG Rostock 2021-08-31
NCT02055092 Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family https://ClinicalTrials.gov/show/NCT02055092 Active, not recruiting Norwegian Centre for Ageing and Health 2017-06-30
NCT01925196 Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation https://ClinicalTrials.gov/show/NCT01925196 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT01465360 Performance of AclarusDxâ„¢, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center https://ClinicalTrials.gov/show/NCT01465360 Completed Exonhit NA
NCT01459302 Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders https://ClinicalTrials.gov/show/NCT01459302 Recruiting University of Massachusetts, Worcester 2021-10-31
NCT01353430 Characterization of Inclusion Body Myopathy Associated With Paget’s Disease of Bone and Frontotemporal Dementia (IBMPFD) https://ClinicalTrials.gov/show/NCT01353430 Recruiting University of California, Irvine 2025-12-31
NCT04413851 Feasibility of Passive Data Collection in Dementia Subjects With Agitation https://ClinicalTrials.gov/show/NCT04413851 Recruiting HealthMode Inc. 2021-06-30
NCT04363684 ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) https://ClinicalTrials.gov/show/NCT04363684 Recruiting Mayo Clinic 2024-07-31
NCT04114994 Longitudinal Cognitive Assessment by BoCA https://ClinicalTrials.gov/show/NCT04114994 Recruiting Alzheimer’s Light LLC 2029-10-01
NCT04104373 The Ontario Neurodegenerative Disease Research Initiative https://ClinicalTrials.gov/show/NCT04104373 Completed Ontario Neurodegeneration Disease Research Initiative 2018-03-31
NCT04060082 Voices Of Individuals: Challenges and Experiences Of bvFTD https://ClinicalTrials.gov/show/NCT04060082 Recruiting University of Pennsylvania 2021-01-31
NCT03967535 Connectomics in Psychiatric Classification https://ClinicalTrials.gov/show/NCT03967535 Completed Washington University School of Medicine 2019-09-05
NCT03912987 TRIAL READY (Clinical Trial Readiness) https://ClinicalTrials.gov/show/NCT03912987 Recruiting University of Miami 2022-01-31
NCT03883750 Induced Pluripotent Stem Cells for Niemann Pick Disease https://ClinicalTrials.gov/show/NCT03883750 Completed Centogene AG Rostock 2019-12-01
NCT03545126 Human CNS Tau Kinetics in Tauopathies https://ClinicalTrials.gov/show/NCT03545126 Recruiting Washington University School of Medicine 2020-12-31
NCT03489278 Clinical Procedures to Support Research in ALS https://ClinicalTrials.gov/show/NCT03489278 Recruiting University of Miami 2024-06-30
NCT00821132 Genetics of Familial and Sporadic ALS https://ClinicalTrials.gov/show/NCT00821132 Recruiting Northwestern University 2019-12-31
NCT00938665 Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISIONâ„¢) as a Useful Cognitive Biomarker for Alzheimer’s Disease. https://ClinicalTrials.gov/show/NCT00938665 Completed Neuronetrix, Inc. 2014-02-28
NCT01899950 Longitudinal Study of Cognition With Niemann-Pick Disease, Type C https://ClinicalTrials.gov/show/NCT01899950 Completed Mayo Clinic 2014-09-30
NCT02860338 COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE https://ClinicalTrials.gov/show/NCT02860338 Completed Clionsky Neuro Systems Inc. 2015-12-31
NCT00677885 P-glycoprotein Function in Brain Diseases https://ClinicalTrials.gov/show/NCT00677885 Completed National Institutes of Health Clinical Center (CC) NA
NCT00613119 PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00613119 Completed National Institutes of Health Clinical Center (CC) NA
NCT00537004 Language in Primary Progressive Aphasia https://ClinicalTrials.gov/show/NCT00537004 Recruiting Northwestern University 2022-04-30
NCT00344331 Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C https://ClinicalTrials.gov/show/NCT00344331 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00088751 Treatment Study of Frontotemporal Dementia https://ClinicalTrials.gov/show/NCT00088751 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02050464 Computational Tools for Early Diagnosis of Memory Disorders https://ClinicalTrials.gov/show/NCT02050464 Completed University of Eastern Finland 2017-04-30
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford https://ClinicalTrials.gov/show/NCT01793168 Recruiting Sanford Health 2100-12-31